Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Translating Unique Learning for Incontinence Prevention: The TULIP Project
Age, VEGF, and skeletal muscle capillarization in humans
Eye/Hand Coordination by Cerebellar Output Neurons
Whitney M. Young Scholars in Science (WYSci)
Field Data: More, Better, Faster
Recently added grants:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
Molecular and Clinical Glycobiology of the Bone Marrow Environment
Core A: Administrative Core
Core B: Glyco-genomics and Bioinformatics
Core C: GAGomics and Proteomics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant